Flexion Therapeutics announces proposed convertible senior notes offering
Flexion announced its intention to offer $125 million principal amount of convertible senior notes due 2024 in a private offering to qualified institutional buyers. Flexion expects to grant initial purchasers of the Notes a 30-day option to purchase up to an additional $18.75 million of Notes. April 25, 2017